Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
ACS Nano ; 13(8): 8749-8759, 2019 08 27.
Artigo em Inglês | MEDLINE | ID: mdl-31322856

RESUMO

The surface of proteins is heterogeneous with sophisticated but precise hydrophobic and hydrophilic patches, which is essential for their diverse biological functions. To emulate such distinct surface patterns on macromolecules, we used rigid spherical synthetic dendrimers (polyphenylene dendrimers) to provide controlled amphiphilic surface patches with molecular precision. We identified an optimal spatial arrangement of these patches on certain dendrimers that enabled their interaction with human adenovirus 5 (Ad5). Patchy dendrimers bound to the surface of Ad5 formed a synthetic polymer corona that greatly altered various host interactions of Ad5 as well as in vivo distribution. The dendrimer corona (1) improved the ability of Ad5-derived gene transfer vectors to transduce cells deficient for the primary Ad5 cell membrane receptor and (2) modulated the binding of Ad5 to blood coagulation factor X, one of the most critical virus-host interactions in the bloodstream. It significantly enhanced the transduction efficiency of Ad5 while also protecting it from neutralization by natural antibodies and the complement system in human whole blood. Ad5 with a synthetic dendrimer corona revealed profoundly altered in vivo distribution, improved transduction of heart, and dampened vector sequestration by liver and spleen. We propose the design of bioactive polymers that bind protein surfaces solely based on their amphiphilic surface patches and protect against a naturally occurring protein corona, which is highly attractive to improve Ad5-based in vivo gene therapy applications.


Assuntos
Adenovírus Humanos/genética , Dendrímeros/farmacologia , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Transdução Genética , Adenovírus Humanos/efeitos dos fármacos , Animais , Proteínas do Capsídeo/química , Dendrímeros/química , Vetores Genéticos/química , Vetores Genéticos/efeitos dos fármacos , Humanos , Interações Hidrofóbicas e Hidrofílicas/efeitos dos fármacos , Fígado/química , Fígado/efeitos dos fármacos , Polímeros/química , Polímeros/farmacologia , Receptores Virais/antagonistas & inibidores , Receptores Virais/química
2.
Nat Commun ; 7: 13520, 2016 11 30.
Artigo em Inglês | MEDLINE | ID: mdl-27901019

RESUMO

Up to 80% of the cost of vaccination programmes is due to the cold chain problem (that is, keeping vaccines cold). Inexpensive, biocompatible additives to slow down the degradation of virus particles would address the problem. Here we propose and characterize additives that, already at very low concentrations, improve the storage time of adenovirus type 5. Anionic gold nanoparticles (10-8-10-6 M) or polyethylene glycol (PEG, molecular weight ∼8,000 Da, 10-7-10-4 M) increase the half-life of a green fluorescent protein expressing adenovirus from ∼48 h to 21 days at 37 °C (from 7 to >30 days at room temperature). They replicate the known stabilizing effect of sucrose, but at several orders of magnitude lower concentrations. PEG and sucrose maintained immunogenicity in vivo for viruses stored for 10 days at 37 °C. To achieve rational design of viral-vaccine stabilizers, our approach is aided by simplified quantitative models based on a single rate-limiting step.


Assuntos
Vacinas contra Adenovirus/farmacologia , Estabilidade de Medicamentos , Excipientes/química , Imunogenicidade da Vacina , Vacinas contra Adenovirus/química , Vacinas contra Adenovirus/imunologia , Animais , Temperatura Baixa , Armazenamento de Medicamentos/métodos , Estudos de Viabilidade , Ouro/química , Meia-Vida , Nanopartículas Metálicas/química , Camundongos , Modelos Animais , Modelos Biológicos , Polietilenoglicóis/química , Sacarose/química , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA